These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis. Shi XJ, Geng F, Jiao Z, Cui XY, Qiu XY, Zhong MK. J Clin Pharm Ther; 2011 Oct; 36(5):614-24. PubMed ID: 21916909 [Abstract] [Full Text] [Related]
7. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups. Li D, Zhang GL, Lou YQ, Li Q, Wang X, Bu XY. J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792 [Abstract] [Full Text] [Related]
9. Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans? Kudzi W, Dodoo AN, Mills JJ. BMC Med Genet; 2010 Jul 14; 11():111. PubMed ID: 20630055 [Abstract] [Full Text] [Related]
11. Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women. Floyd MD, Gervasini G, Masica AL, Mayo G, George AL, Bhat K, Kim RB, Wilkinson GR. Pharmacogenetics; 2003 Oct 14; 13(10):595-606. PubMed ID: 14515058 [Abstract] [Full Text] [Related]
12. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. Ogasawara K, Chitnis SD, Gohh RY, Christians U, Akhlaghi F. Clin Pharmacokinet; 2013 Sep 14; 52(9):751-62. PubMed ID: 23633119 [Abstract] [Full Text] [Related]
13. The Frequencies distribution of CYP3A5 rs776746 and ABCB1 rs1045642 polymorphisms in the west Algerian population and relationships with pharmacogenetics. Ammour A, Aberkane M, Boudjema A, Boughrara W, Benchekor SM. Afr Health Sci; 2024 Mar 14; 24(1):307-312. PubMed ID: 38962329 [Abstract] [Full Text] [Related]
14. Genetic contribution to variable human CYP3A-mediated metabolism. Lamba JK, Lin YS, Schuetz EG, Thummel KE. Adv Drug Deliv Rev; 2002 Nov 18; 54(10):1271-94. PubMed ID: 12406645 [Abstract] [Full Text] [Related]
15. Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation. Turolo S, Tirelli AS, Ferraresso M, Ghio L, Belingheri M, Groppali E, Torresani E, Edefonti A. Pharmacol Rep; 2010 Nov 18; 62(6):1159-69. PubMed ID: 21273673 [Abstract] [Full Text] [Related]
16. CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population. Mirghani RA, Sayi J, Aklillu E, Allqvist A, Jande M, Wennerholm A, Eriksen J, Herben VM, Jones BC, Gustafsson LL, Bertilsson L. Pharmacogenet Genomics; 2006 Sep 18; 16(9):637-45. PubMed ID: 16906018 [Abstract] [Full Text] [Related]
18. Tacrolimus concentrations in relation to CYP3A and ABCB1 polymorphisms among solid organ transplant recipients in Korea. Jun KR, Lee W, Jang MS, Chun S, Song GW, Park KT, Lee SG, Han DJ, Kang C, Cho DY, Kim JQ, Min WK. Transplantation; 2009 Apr 27; 87(8):1225-31. PubMed ID: 19384171 [Abstract] [Full Text] [Related]
20. Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients. Miao LY, Huang CR, Hou JQ, Qian MY. Biopharm Drug Dispos; 2008 Jan 27; 29(1):1-5. PubMed ID: 17941052 [Abstract] [Full Text] [Related] Page: [Next] [New Search]